Avanos Medical reported revenue of $182.20M and net income of $5.10M for the quarter ended Mar 2026, up 8.8% year over year. This income statement covers 51 quarters of results from Sep 2013 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 186.40M | 184.10M | 35.80M | 197.40M | 170.90M | 172.30M | 181.60M | 159.30M | 169.40M | 171.30M | 173.30M | 166.10M | 171.70M | 170.40M | 179.60M | 167.50M | 175.00M | 177.80M | 180.90M | 182.20M | |||||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 100.00M | 93.90M | 3.50M | 90.80M | 69.30M | 72.10M | 78.70M | 67.90M | 71.60M | 75.80M | 78.30M | 71.30M | 76.10M | 77.50M | 81.60M | 77.70M | 82.90M | 91.80M | 94.90M | 88.00M | |||||||||||||||||||||||||||||||
| Gross Profit | 85.70M | 90.20M | 32.30M | 106.60M | 101.60M | 100.20M | 102.90M | 91.40M | 97.80M | 95.50M | 95.00M | 94.80M | 95.60M | 92.90M | 98.00M | 89.80M | 92.10M | 86.00M | 86.00M | 94.20M | |||||||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 8.00M | 8.40M | 5.90M | 7.80M | 7.60M | 7.10M | 7.20M | 7.50M | 6.80M | 6.10M | 6.80M | 7.00M | 6.30M | 7.20M | 5.70M | 5.40M | 5.80M | 6.00M | 6.10M | 5.20M | |||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 76.70M | 75.00M | 60.20M | 90.10M | 83.20M | 78.30M | 78.70M | 88.80M | 93.00M | 78.70M | 74.50M | 83.60M | 80.90M | 74.30M | 79.70M | 75.70M | 83.50M | 77.60M | 78.80M | 77.70M | |||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -8.30M | -3.40M | 11.40M | -0.10M | -0.70M | -2.00M | -0.40M | -1.20M | -0.10M | -9.50M | -2.50M | -0.20M | -2.10M | 0.60M | 5.60M | 1.60M | -0.30M | -2.30M | 1.40M | -2.40M | |||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 84.70M | 83.40M | 66.10M | 97.90M | 90.80M | 85.40M | 85.90M | 96.30M | 99.80M | 84.80M | 81.30M | 90.60M | 87.20M | 81.50M | 85.40M | 81.10M | 89.30M | 83.60M | 84.90M | 82.90M | |||||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -7.30M | 3.40M | -22.40M | 8.60M | 10.10M | 12.80M | 16.60M | -6.10M | -2.10M | 1.20M | 11.20M | 4.00M | 6.30M | 12.00M | -418.50M | 10.30M | -74.50M | 0.10M | 2.50M | 8.90M | |||||||||||||||||||||||||||||||
| EBIT | -7.30M | 3.40M | -22.40M | 8.60M | 10.10M | 12.80M | 16.60M | -6.10M | -2.10M | 1.20M | 11.20M | 4.00M | 6.30M | 12.00M | -418.50M | 10.30M | -74.50M | 0.10M | 2.50M | 8.90M | |||||||||||||||||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.90M | 0.90M | 0.70M | 1.30M | 2.70M | 3.00M | 3.00M | 3.50M | 3.50M | 4.70M | 3.30M | 3.10M | 3.10M | 3.20M | 2.80M | 2.10M | 2.00M | 1.80M | 1.90M | 1.50M | |||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.20M | 0.20M | 0.30M | 0.70M | 0.50M | 0.50M | 0.90M | 1.00M | 0.60M | 3.00M | 0.70M | 0.80M | 1.50M | 0.60M | 0.50M | 0.60M | 0.20M | ||||||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -7.50M | 2.70M | -23.10M | 7.30M | 7.60M | 10.10M | 14.30M | -9.10M | -5.10M | -2.60M | 8.90M | 1.50M | 6.20M | 9.50M | -420.50M | 9.70M | -75.90M | -1.20M | 1.20M | 7.60M | |||||||||||||||||||||||||||||||
| Tax ProvisionsTaxes | -46.00M | 38.00M | 2.60M | 1.90M | 2.80M | -0.90M | 4.60M | -1.30M | -0.80M | 6.20M | -2.10M | 1.00M | 1.90M | 3.60M | -23.50M | 3.10M | 0.90M | 0.20M | 2.50M | 2.50M | |||||||||||||||||||||||||||||||
| Profit After TaxPAT | 38.50M | -35.30M | -25.70M | 5.40M | 12.50M | 15.70M | 16.90M | -7.80M | -68.10M | -8.80M | 10.50M | -0.90M | 4.30M | 5.90M | -402.80M | 6.60M | -76.80M | -1.40M | -1.30M | 5.10M | |||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 38.50M | -35.30M | -25.70M | 5.40M | 4.80M | 11.00M | 9.70M | -7.80M | -4.30M | -8.80M | 11.00M | 0.50M | 4.30M | 5.90M | -397.00M | 6.60M | -76.80M | -1.40M | -1.30M | 5.10M | |||||||||||||||||||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | 7.70M | 4.70M | 7.20M | 7.30M | -63.80M | 5.10M | -0.50M | -1.40M | -2.50M | -1.60M | -0.30M | ||||||||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 38.50M | -35.30M | -25.70M | 5.40M | 12.50M | 15.70M | 16.90M | -0.50M | -68.10M | -3.70M | 10.50M | -0.90M | 1.80M | 4.30M | -397.30M | 6.60M | -76.80M | -1.40M | -1.30M | 5.10M | |||||||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 38.50M | -35.30M | -25.70M | 5.40M | 12.50M | 15.70M | 16.90M | -0.50M | -68.10M | -3.70M | 10.50M | -0.90M | 1.80M | 4.30M | -397.30M | 6.60M | -76.80M | -1.40M | -1.30M | 5.10M | |||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | 38.50M | -35.30M | -25.70M | 5.40M | 12.50M | 15.70M | 16.90M | -0.50M | -68.10M | -3.70M | 10.50M | -0.90M | 1.80M | 4.30M | -397.30M | 6.60M | -76.80M | -1.40M | -1.30M | 5.10M | |||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.80 | -0.73 | -0.53 | 0.11 | 0.26 | 0.34 | 0.36 | -0.01 | -1.46 | -0.08 | 0.23 | -0.02 | 0.04 | 0.09 | -8.64 | 0.14 | -1.66 | -0.03 | -0.03 | 0.11 | |||||||||||||||||||||||||||||||
| EPS (Diluted) | 0.79 | -0.73 | -0.53 | 0.11 | 0.26 | 0.33 | 0.36 | -0.01 | -1.46 | -0.08 | 0.23 | -0.02 | 0.04 | 0.09 | -8.64 | 0.14 | -1.66 | -0.03 | -0.03 | 0.11 | |||||||||||||||||||||||||||||||
| Shares Outstanding | 48.10M | 48.10M | 48.10M | 47.40M | 47.20M | 46.60M | 46.90M | 46.60M | 46.80M | 46.80M | 46.60M | 46.20M | 45.90M | 46.00M | 46.00M | 46.10M | 46.30M | 46.40M | 46.30M | 46.50M | |||||||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 48.60M | 48.10M | 48.60M | 47.80M | 47.60M | 47.00M | 47.30M | 47.20M | 46.80M | 46.80M | 46.60M | 46.70M | 46.30M | 46.60M | 46.00M | 46.80M | 46.30M | 46.40M | 46.30M | 47.50M | |||||||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 48.10M | 48.13M | 48.21M | 47.32M | 46.85M | 46.50M | 46.53M | 46.66M | 46.83M | 46.43M | 46.17M | 46.07M | 45.91M | 45.95M | 45.96M | 46.24M | 46.31M | 46.42M | 46.46M | 46.67M | |||||||||||||||||||||||||||||||
| EBITDA | -7.30M | 3.40M | -22.40M | 8.60M | 10.10M | 12.80M | 16.60M | -6.10M | -2.10M | 1.20M | 11.20M | 4.00M | 6.30M | 12.00M | -418.50M | 10.30M | -74.50M | 0.10M | 2.50M | 8.90M | |||||||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 0.90M | 0.90M | 0.70M | 1.30M | 2.70M | 3.00M | 3.00M | 3.50M | 3.50M | 4.70M | 3.30M | 3.10M | 3.10M | 3.20M | 2.80M | 2.10M | 2.00M | 1.80M | 1.90M | 1.50M | |||||||||||||||||||||||||||||||
| Tax Rate | 613.33% | 1,407.41% | -11.26% | 26.03% | 36.84% | -8.91% | 32.17% | 14.29% | 15.69% | -238.46% | -23.60% | 66.67% | 30.65% | 37.89% | 5.59% | 31.96% | -1.19% | -16.67% | 208.33% | 32.89% |